Masimo settles Shaklee, NIR pulse oximeter patent dispute
This article was originally published in Clinica
Executive Summary
Patient monitoring specialist Masimo (Irvine, California) has settled a pending patent dispute over pulse oximeter technology with its rivals Shaklee and NIR Diagnostics, ending legal proceedings after more than a year. All claims of patent litigation against Masimo were dismissed as the settlement was reached without Masimo incurring any liability to the plaintiffs. Shaklee had originally filed a lawsuit against Masimo in July 2007, claiming that that the latter’s patented pulse oximeters used calibration methods that had already been licensed. NIR joined the litigation alongside Shaklee, as both companies sought damages and an injunction preventing Masimo from selling its oximeters. Financial details of the settlement, if any, were not disclosed.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals